UPDATE : Monday, December 9, 2019
상단여백
SK Biopharm's antiepileptic drug is 1st local medicine to win FDA nod independently
SK Biopharmaceuticals' XCOPRI, a treatment for partial-onset seizures i...
by Lee Han-soo  |  2019-11-22 17:03
라인
Bridge Biotherapeutics aims to become global NRDO company
Bridge Biotherapeutics revealed its goal to become Korea's top no resea...
by Lee Han-soo  |  2019-11-22 15:10
라인
‘SGLT-2 inhibitor may prevent retinopathy in type-2 diabetes’
Researchers at Ajou University Hospital said sodium-glucose cotransporter-2...
by Lee Han-soo  |  2019-11-21 15:21
라인
‘Sprycel showed longer efficacy than nilotinib for chronic myeloid leukemia’
Bristol-Myers Squibb (BMS) has published the results of an observational st...
by Lee Han-soo  |  2019-11-21 14:26
라인
CJ HealthCare to export gastric acid blocker to Thailand
CJ HealthCare said Thursday that it planned to export K-Cab (Ingredient: te...
by Lee Han-soo  |  2019-11-21 10:54
라인
‘Japan much advanced than Korea in ALK-positive NSCLC treatment’
Japan moved fast to authorize to use lorlatinib, a third-generation targete...
by Kim Yun-mi  |  2019-11-20 16:16
라인
Remed aims to expand global presence through IPO
Remed expressed its aspiration to become a global leader in the newly emerg...
by Lee Han-soo  |  2019-11-20 15:30
라인
PharmAbcine registers 1st patient for phase-2 trial on olinvacimab
PharmAbcine, a developer of antibody drugs, said it has registered the firs...
by Jeong Sae-im  |  2019-11-19 17:18
라인
‘Udenafil improved exercise in single ventricle heart disease’
Mezzion Pharma said its investigational drug udenafil improved exercise cap...
by Jeong Sae-im  |  2019-11-18 14:48
라인
“Xalkori-Alecensa sequential therapy advantageous in duration of treatment”
Given the licensing and insurance system in Korea, the Xalkori-Alecensa seq...
by Kim Yun-mi  |  2019-11-15 17:48
라인
Ministry revokes Kolon Life Science’s innovative drug company status
The Ministry of Health and Welfare revoked Kolon Life Science’s innovative ...
by Lee Han-soo  |  2019-11-15 17:26
라인
AbbVie presents new data for ankylosing spondylitis treatment in US
AbbVie has presented positive data from its phase 2 and 3 SELECT-AXIS 1 tri...
by Lee Han-soo  |  2019-11-15 11:40
라인
Merck Korea wins award for helping families with infertility problems
Merck Biopharma Korea said that it received the National Assembly's Hea...
by Lee Han-soo  |  2019-11-14 18:05
라인
Prosecutors raid drugmakers, distributors for suspected bid-rigging
Prosecutors have begun investigating local drug companies and distributors ...
by Jeong Sae-im  |  2019-11-14 15:27
라인
‘Novartis’ Kymriah takes one step closer to cancer cure’
Novartis has recently drawn the attention of local industry watchers concer...
by Lee Han-soo  |  2019-11-14 13:24
라인
iCure to apply for testing incrementally modified cancer drugs in US
iCure BNP said that it plans to apply for a phase 1 trial to change antican...
by Lee Han-soo  |  2019-11-13 17:35
라인
JW Pharmaceutical launches joint-stock company in Vietnam
JW Pharmaceutical said that it has formally launched Euvipharm Joint Stock ...
by Lee Han-soo  |  2019-11-13 16:52
라인
‘Generic drugs must indicate ingredient names on label’
“The results of ranitidine’s recall were sharply different from those of va...
by Kim Yun-mi  |  2019-11-13 15:51
라인
Daewoong releases trial results for autoimmune disease treatment in US
Daewoong Pharmaceutical has presented clinical trial results on DWP212525, ...
by Lee Han-soo  |  2019-11-12 14:09
라인
Hanmi to get ₩11.6 billion in royalty if FDA approves Rolontis
Spectrum, Hanmi’s U.S. partner, said Hanmi can secure 11.6 billion won ($9....
by Lee Han-soo  |  2019-11-11 18:02
여백
여백
여백
Back to Top